Keywords: Eli Lilly, Third-quarter 2011 finacial results

Eli Lilly 3rd-qtr 2011 sales grow 9% but costs hit profits

Article | 21 October 2011

Print This

US drug major Eli Lilly (NYSE: LLY) posted financial results for the third quarter of 2011 showing that, while sales increased 9% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in